REDWOOD-LIVER
Who is this for?
Alpha-1 antitrypsin deficiency patients with a ZZ genotype and moderate-severe liver fibrosis
Study:
This study looks at the drug fazirsiran. It aims to observe the efficacy of the investigational drug compared to placebo at improving AATD induced liver fibrosis.